{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T11:59:19Z","timestamp":1773230359463,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.hpb.2025.09.005","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:55:35Z","timestamp":1758592535000},"page":"1552-1562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a prognostic nomogram for postoperative survival in hilar cholangiocarcinoma using SEER and institutional cohorts"],"prefix":"10.1016","volume":"27","author":[{"given":"Minglong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aijun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2025.09.005_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.hpb.2025.09.005_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hpb.2025.09.005_bib3","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2025.09.005_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hpb.2025.09.005_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.104003","article-title":"Electronic address: clinicalguidelines@esmo.org. ESMO clinical practice guideline interim update on the management of biliary tract cancer","volume":"10","author":"Vogel","year":"2025","journal-title":"ESMO Open"},{"issue":"8 Suppl","key":"10.1016\/j.hpb.2025.09.005_bib6","article-title":"Overview of the SEER-medicare data: content, applications, and generalizability for the elderly","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.hpb.2025.09.005_bib7","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/bjc.2017.315","article-title":"Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms","volume":"117","author":"Fang","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hpb.2025.09.005_bib8","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hpb.2025.09.005_bib9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jnci\/djj234","article-title":"Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States","volume":"98","author":"Welzel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.hpb.2025.09.005_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42047-024-00160-6","article-title":"The biliary tree musketeers: cholangiocarcinoma \u2013 one name for all, but at least three different diseases with distinct targets","volume":"7","author":"Marins","year":"2024","journal-title":"Surg Exp Pathol"},{"key":"10.1016\/j.hpb.2025.09.005_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107064","article-title":"Epidemiology of cholangiocarcinoma","volume":"51","author":"Qurashi","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2025.09.005_bib12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/SLA.0000000000005103","article-title":"Perihilar cholangiocarcinoma - novel benchmark values for surgical and oncological outcomes from 24 expert centers","volume":"274","author":"Mueller","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.09.005_bib13","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1245\/s10434-024-15115-0","article-title":"Higher postoperative mortality and inferior survival after right-sided liver resection for perihilar cholangiocarcinoma: Left-sided resection is preferred when possible","volume":"31","author":"Olthof","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2025.09.005_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ciresp.2013.07.015","article-title":"Colangiocarcinoma hiliar: el n\u00famero de ganglios positivos y la relaci\u00f3n ganglios positivos\/ganglios totales son un factor pron\u00f3stico importante de supervivencia","volume":"92","author":"Nari","year":"2014","journal-title":"Cir Esp"},{"key":"10.1016\/j.hpb.2025.09.005_bib15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MEG.0000000000000162","article-title":"Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?","volume":"26","author":"Hakeem","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2025.09.005_bib16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s11605-021-05211-x","article-title":"Evaluation of four lymph node classifications for the prediction of survival in hilar cholangiocarcinoma","volume":"26","author":"Liu","year":"2022","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2025.09.005_bib17","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/annonc\/mdv279","article-title":"Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram","volume":"26","author":"Groot","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2025.09.005_bib18","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ejso.2021.12.002","article-title":"Adjuvant chemotherapy for perihilar cholangiocarcinoma: a population-based comparative cohort study","volume":"48","author":"Kamarajah","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2025.09.005_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.hbpd.2018.11.001","article-title":"The effect of adjuvant chemotherapy in resectable cholangiocarcinoma: a meta-analysis and systematic review","volume":"18","author":"Wang","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hpb.2025.09.005_bib20","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s00432-021-03524-7","article-title":"Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma","volume":"147","author":"Im","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.hpb.2025.09.005_bib21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s00595-005-2989-4","article-title":"Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma","volume":"35","author":"Sagawa","year":"2005","journal-title":"Surg Today"},{"key":"10.1016\/j.hpb.2025.09.005_bib22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00000658-199506000-00017","article-title":"Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival","volume":"221","author":"Pitt","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2025.09.005_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1586\/egh.12.20","article-title":"Management of perihilar cholangiocarcinoma in the era of multimodal therapy","volume":"6","author":"Valero","year":"2012","journal-title":"Expet Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2025.09.005_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s40001-025-02654-9","article-title":"Prognostic impact of lymph node and surgical margin in patients with perihilar cholangiocarcinoma","volume":"30","author":"Yang","year":"2025","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.hpb.2025.09.005_bib25","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1245\/s10434-024-15582-5","article-title":"Comparing survival of perihilar cholangiocarcinoma after R1 resection versus palliative chemotherapy for unresected localized disease","volume":"31","author":"van Keulen","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2025.09.005_bib26","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1245\/s10434-020-09135-9","article-title":"Stratification of postoperative prognosis by invasive tumor thickness in perihilar cholangiocarcinoma","volume":"28","author":"Oba","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2025.09.005_bib27","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3390\/jcm10071345","article-title":"Prognostic impact of perioperative CA19-9 levels in patients with resected perihilar cholangiocarcinoma","volume":"10","author":"Lee","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.hpb.2025.09.005_bib28","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3390\/medicina58121788","article-title":"Klatskin tumor: a survival analysis according to tumor characteristics and inflammatory ratios","volume":"58","author":"Nechita","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.hpb.2025.09.005_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304838","article-title":"Clinical features and prediction of long-term survival after surgery for perihilar cholangiocarcinoma","volume":"19","author":"Mantas","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2025.09.005_bib30","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.surg.2015.04.032","article-title":"Impact of portal vein resection on oncologic long-term outcome in patients with hilar cholangiocarcinoma","volume":"158","author":"Hoffmann","year":"2015","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2025.09.005_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/HEP.0000000000000554","article-title":"Predicting futility of upfront surgery in perihilar cholangiocarcinoma: machine learning analytics model to optimize treatment allocation","volume":"79","author":"Ratti","year":"2024","journal-title":"Hepatology"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25016211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25016211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:01:27Z","timestamp":1773154887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X25016211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1365182X25016211"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2025.09.005","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a prognostic nomogram for postoperative survival in hilar cholangiocarcinoma using SEER and institutional cohorts","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2025.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}